The role of interferons in the control of HIV replication in macrophages
- PMID: 1688522
- DOI: 10.1016/0090-1229(90)90082-2
The role of interferons in the control of HIV replication in macrophages
Abstract
Interferons can suppress the replication of certain retroviruses, including oncogenic murine retroviruses. In recent studies of the Lentivirinae subfamily of Retroviridae, an endogenous, immunologically induced interferon was found to restrict the replication of visna in macrophages. Several studies have shown that the replication of a human lentivirus, the human immunodeficiency virus (HIV), is also susceptible to interferon control. Here we review the evidence that interferons can protect macrophages from HIV in vitro. Macrophages treated with interferons or bacterial lipopolysaccharide (LPS) become essentially nonpermissive for HIV replication. Using the polymerase chain reaction to amplify HIV proviral DNA, we now report that interferon and LPS act to restrict the formation of proviral DNA. Effects on any several steps in the HIV life cycle may explain this data, and single-cycle infection studies are needed to define the precise roles of these agents. Taken together, these findings may explain the restricted replication of HIV in macrophages in vivo and suggest an antiviral role for endogenously produced interferon in the maintenance of the prolonged asymptomatic period which typically follows HIV infection. Interferons are currently undergoing clinical trials to determine if they have antiviral effects in HIV-infected patients.
Similar articles
-
Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.J Exp Med. 1989 Mar 1;169(3):1137-51. doi: 10.1084/jem.169.3.1137. J Exp Med. 1989. PMID: 2466937 Free PMC article.
-
Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages.Virology. 1993 Mar;193(1):138-48. doi: 10.1006/viro.1993.1110. Virology. 1993. PMID: 7679856
-
Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro.AIDS Res Hum Retroviruses. 1987 Summer;3(2):125-33. doi: 10.1089/aid.1987.3.125. AIDS Res Hum Retroviruses. 1987. PMID: 3113463
-
Multiple effects of interferon on the replication of human immunodeficiency virus type 1.Antiviral Res. 1994 Jul;24(2-3):205-19. doi: 10.1016/0166-3542(94)90068-x. Antiviral Res. 1994. PMID: 7526792 Review.
-
Interferon action on membrane-associated viruses: a minireview.J Exp Pathol. 1990;5(2):49-51. J Exp Pathol. 1990. PMID: 1708816 Review. No abstract available.
Cited by
-
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome.Cytokine Growth Factor Rev. 2018 Apr;40:19-31. doi: 10.1016/j.cytogfr.2018.03.003. Epub 2018 Mar 16. Cytokine Growth Factor Rev. 2018. PMID: 29576284 Free PMC article. Review.
-
Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro.Clin Diagn Lab Immunol. 1996 Sep;3(5):547-53. doi: 10.1128/cdli.3.5.547-553.1996. Clin Diagn Lab Immunol. 1996. PMID: 8877133 Free PMC article.
-
HLA-associated susceptibility to HIV-1 infection.Clin Exp Immunol. 1992 Jan;87(1):20-3. doi: 10.1111/j.1365-2249.1992.tb06407.x. Clin Exp Immunol. 1992. PMID: 1733633 Free PMC article.
-
A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes.J Exp Med. 1990 Nov 1;172(5):1433-42. doi: 10.1084/jem.172.5.1433. J Exp Med. 1990. PMID: 2264889 Free PMC article.
-
CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages.J Leukoc Biol. 2018 Feb 13;103(6):1225-40. doi: 10.1002/JLB.3MIA0917-352R. Online ahead of print. J Leukoc Biol. 2018. PMID: 29437254 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical